Sassi Nir has filed 10 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 26758 shares of Indaptus Therapeutics, Inc. ($INDP) on December 22, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 22, 2025 | Indaptus Therapeutics, Inc. | $INDP | Sassi Nir | Chief Financial Officer | A | Common Stock | 26758 | $2.03 | 26,758.0000 | 1,641,920 | 9999.99% | 1.63% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 1125 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 2500 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.02% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 500 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 500 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 1250 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 1125 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 41 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| Oct. 9, 2024 | Indaptus Therapeutics, Inc. | $INDP | Sassi Nir | Chief Financial Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 8,401,047 | 9999.99% | 0.89% |
| Jan. 22, 2024 | Indaptus Therapeutics, Inc. | $INDP | Sassi Nir | Chief Financial Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 8,401,047 | 9999.99% | 0.48% |